GlassScriptPhysician profile
David M Heath
NPI 1699130252
$2,717.27
in general payments reported to CMS, 2019-2025
23 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,105 · 2023: $995 · 2024: $269 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $758.66 | 2022-2024 | Xtampza |
| Abbvie INC. | $451.33 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $346.50 | 2022 | |
| Lilly USA, LLC | $263.71 | 2022-2025 | Reyvow, Emgality, Jardiance |
| Allergan, INC. | $248.17 | 2022 | |
| Scilex Pharmaceuticals INC. | $148.37 | 2022-2024 | Ztlido |
| Pfizer INC. | $93.80 | 2023-2025 | |
| Lundbeck LLC | $54.78 | 2023 | Vyepti |
| Kowa Pharmaceuticals America, INC. | $46.82 | 2022-2025 | Zoryve |
| Takeda Pharmaceuticals U.S.A., INC. | $39.11 | 2023 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $30.86 | 2025 | Breztri |
| Teleflex LLC | $28.40 | 2025 | Urolift |
| Exactech, INC. | $26.70 | 2023 | |
| Almatica Pharma LLC | $24.64 | 2025 | Loreev Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.13 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.08 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $19.53 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.34 | 2024 | |
| Glaxosmithkline, LLC. | $18.10 | 2025 | Trelegy Ellipta |
| Corcept Therapeutics | $17.76 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $16.72 | 2025 | Inspire |
| Amgen INC. | $14.30 | 2025 | Evenity, Prolia |
| Phathom Pharmaceuticals, INC. | $7.46 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Heath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.